Avadel Pharma (AVDL) Misses Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts AVDL Hot Sheet
Join SI Premium – FREE
Avadel Pharma (NASDAQ: AVDL) reported Q4 EPS of ($0.32), $0.04 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $19.45 million versus the consensus estimate of $18.21 million.
For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Worthington Industries (WOR) Tops Q1 EPS by 7c
- General Mills beats estimates as cost savings offset volumes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
